β-blockers in Chronic Obstructive Pulmonary Disease: a Cohort Study from the TONADO<sup>®</sup> Research Programme.
| Author | |
|---|---|
| Abstract |
:
Cardiovascular disease is a frequent co-morbidity in patients with chronic obstructive pulmonary disease (COPD). Many clinicians, particularly pulmonologists, are reluctant to use β-adrenoceptor blocking agents (β-blockers) in patients with COPD, despite their proven effectiveness in preventing cardiovascular events. |
| Year of Publication |
:
2018
|
| Journal |
:
Chest
|
| Date Published |
:
2018
|
| ISSN Number |
:
0012-3692
|
| URL |
:
http://linkinghub.elsevier.com/retrieve/pii/S0012-3692(18)30080-1
|
| DOI |
:
10.1016/j.chest.2018.01.008
|
| Short Title |
:
Chest
|
| Download citation |
